KARDIOTROPES MITTEL AUF DER BASIS VON GLYKOSID UND EINEM BETA-ADRENERGISCHEN REIZMITTEL
The invention relates to cardiology and presents a cardiotropic agent REFRAKTERIN based on the cardiac glycoside and the beta -adrenergic stimulator and further contains nicotinamide adenine dinucleotide, cytochrome C and inosine. REFRAKTERIN restores the contractility and increases the reserves of...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to cardiology and presents a cardiotropic agent REFRAKTERIN based on the cardiac glycoside and the beta -adrenergic stimulator and further contains nicotinamide adenine dinucleotide, cytochrome C and inosine. REFRAKTERIN restores the contractility and increases the reserves of the myocardium in the pronounced and severe form of heart failure. |
---|